Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Feb;52(2):528–532. doi: 10.1172/JCI107212

Control of Thyroid Hormone Secretion in Normal Subjects Receiving Iodides

Apostolos G Vagenakis 1,2, Patricia Downs 1,2, Lewis E Braverman 1,2, Albert Burger 1,2, Sidney H Ingbar 1,2
PMCID: PMC302285  PMID: 4683889

Abstract

The administration of exogenous iodides (saturated solution of potassium iodide, SSKI) to normal male volunteers resulted in a significant decrease in the serum concentration of thyroxine (T4) and triiodothyronine (T3) and a significant increase in serum concentration of thyrotropin (TSH). During the control period (phase I), serum concentrations of T4 averaged 6.9±1.8 μg/100 ml (mean ±SD), T3 106±15 ng/100 ml, and TSH 3.7±1.3 μU/ml. During the administration of 1 drop of SSKI twice daily for 11 days (phase II), there was a small but significant decrease in the serum concentration of T4 and T3 (5.8±1.6 μg/100 ml and 91±19 ng/100 ml, respectively) and a small but significant increase in the serum concentration of TSH (6.0±3.5 μU/ml). During the administration of 5 drops of SSKI twice daily (phase III) over the following 12-19 days, these changes persisted, except for a small increase in the serum concentration of T3 (97±20 ng/100 ml), which was statistically significant when compared to values obtained during phase II. Values returned to control levels 14 days after withdrawal of SSKI. Almost all these observed changes took place within the limits of the normal range. It is postulated that, in euthyroid individuals, iodides specifically inhibit release of T4 and probably of T3. The resulting slight decrease in values for serum T4 and T3 elicits a small increase in TSH secretion which, it is postulated, antagonizes the inhibition of hormone release induced by iodides. As a result, a new equilibrium is reached which maintains the euthyroid state.

Full text

PDF
528

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braverman L. E., Ingbar S. H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970 May;49(5):855–864. doi: 10.1172/JCI106304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braverman L. E., Vagenakis A. G., Foster A. E., Ingbar S. H. Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration. J Clin Endocrinol Metab. 1971 Apr;32(4):497–502. doi: 10.1210/jcem-32-4-497. [DOI] [PubMed] [Google Scholar]
  3. Buhler U. K., DeGroot L. J. Effect of stable iodine on thyroid iodine release. J Clin Endocrinol Metab. 1969 Dec;29(12):1546–1552. doi: 10.1210/jcem-29-12-1546. [DOI] [PubMed] [Google Scholar]
  4. DEGROOT L. J., GREER M. A. The effect of stable iodide on thyroid secretion in man. Metabolism. 1956 Nov;5(6 Pt 1):682–696. [PubMed] [Google Scholar]
  5. DeGroot L. J. Action of potassium iodide on thyroxine metabolism. J Clin Endocrinol Metab. 1966 Jul;26(7):778–779. doi: 10.1210/jcem-26-7-778. [DOI] [PubMed] [Google Scholar]
  6. GOLDSMITH R. E., EISELE M. L. The effect of iodide on the release of thyroid hormone in hyperthyroidism. J Clin Endocrinol Metab. 1956 Jan;16(1):130–137. doi: 10.1210/jcem-16-1-130. [DOI] [PubMed] [Google Scholar]
  7. Hall R., Amos J., Ormston B. J. Radioimmunoassay of human serum thyrotrophin. Br Med J. 1971 Mar 13;1(5749):582–585. doi: 10.1136/bmj.1.5749.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MATSUDA K., GREER M. A. NATURE OF THYROID SECRETION IN THE RAT AND THE MANNER IN WHICH IT IS ALTERED BY THYROTROPIN. Endocrinology. 1965 Jun;76:1012–1021. doi: 10.1210/endo-76-6-1012. [DOI] [PubMed] [Google Scholar]
  9. SOLOMON D. H. Factors affecting the fractional rate of release of radioiodine from the thyroid gland in man. Metabolism. 1956 Nov;5(6 Pt 1):667–681. [PubMed] [Google Scholar]
  10. Sawin C. T., Hershman J. M., Handler S. D., Utiger R. D. Attempts to augment thyrotropin secretion. Effects of methimazole, methimazole-iodide, vasopressin, and glucagon. Metabolism. 1970 Jul;19(7):488–492. doi: 10.1016/0026-0495(70)90003-x. [DOI] [PubMed] [Google Scholar]
  11. Snyder P. J., Utiger R. D. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest. 1972 Aug;51(8):2077–2084. doi: 10.1172/JCI107014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wartofsky L., Ransil B. J., Ingbar S. H. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest. 1970 Jan;49(1):78–86. doi: 10.1172/JCI106225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wolff J. Iodide goiter and the pharmacologic effects of excess iodide. Am J Med. 1969 Jul;47(1):101–124. doi: 10.1016/0002-9343(69)90245-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES